A randomized, double-blind phase II trial of exemestane with or without MM-121 in postmenopausal women with locally advanced or metastatic estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+), HER2-negative breast cancer
| العنوان: | A randomized, double-blind phase II trial of exemestane with or without MM-121 in postmenopausal women with locally advanced or metastatic estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+), HER2-negative breast cancer |
|---|---|
| المؤلفون: | Victor Moyo, Paul E. Goss, R. Aravelo-Araujo, M. Higgins, V. Charu, N. Iannotti, N. Dhindsa |
| المصدر: | Journal of Clinical Oncology. 29:TPS112-TPS112 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2011. |
| سنة النشر: | 2011 |
| مصطلحات موضوعية: | Oncology, Cancer Research, medicine.medical_specialty, Postmenopausal women, Combination therapy, business.industry, Locally advanced, Estrogen receptor, medicine.disease, Double blind, Progesterone Receptor Positive, chemistry.chemical_compound, Breast cancer, Endocrinology, Exemestane, chemistry, Internal medicine, medicine, business |
| الوصف: | TPS112 Background: Resistance to endocrine therapy (ET) is a common challenge in breast cancer. In treatment regimes involving exemestane, combination therapy employing MM-121 presents the potentia... |
| تدمد: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2011.29.15_suppl.tps112 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::8f5f2d7b9a00be86c5edc97f1bbe6273 https://doi.org/10.1200/jco.2011.29.15_suppl.tps112 |
| رقم الانضمام: | edsair.doi...........8f5f2d7b9a00be86c5edc97f1bbe6273 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|---|
| DOI: | 10.1200/jco.2011.29.15_suppl.tps112 |